Drug class in one race
Cardiac myosin (activator) drugs for Heart Failure
2 tracked Cardiac myosin (activator) drugs in the Heart Failure race. The class explanation lives on the Cardiac myosin (activator) page; the full indication pipeline across every mechanism is on the Heart Failure page.
1 Phase 31 Phase 1/2
Head-to-head evidence: Danicamtiv vs Omecamtiv mecarbil